ArticlePloS one2020

Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma.

Hirofumi Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.